|
Baseline potential risk factors*
|
Adjusted-OR**
|
95%CI
|
p
|
|---|
|
MetS component
| | | |
|
COB
|
7.5
|
4.0 - 14.2
|
<0.01
|
|
Hyper-TG
|
2.4
|
1.5 - 3.7
|
<0.01
|
|
Hyper-GL
|
2.2
|
1.4 - 3.3
|
<0.01
|
|
Low-HDL
|
2.7
|
1.8 - 4.0
|
<0.01
|
|
HBP
|
2.5
|
1.6 - 3.9
|
<0.01
|
|
Hyperuricemia
|
1.0
|
0.6 - 1.6
|
0.98
|
|
Sonographic fatty liver
|
2.3
|
1.6 - 3.5
|
<0.01
|
|
Elevated alanine aminotransferase
|
1.3
|
0.8 - 2.1
|
0.36
|
|
Elevated γ-glutamil transferase
|
2.0
|
1.3 - 3.1
|
<0.01
|
|
Hyperinsulinemia
|
1.7
|
1.1 - 2.6
|
<0.01
|
- * Abbreviations: Hyper-GL, hyperglycemia; Low-HDL, Low-HDL cholesterolemia; HBP, High blood pressure; Hyper-TG, hypertriglyceridemia; COB, central obesity
- ** Adjusted variables were age and categorical variables including gender, smoking, diet habits, drinking, exercise status, sonographic liver enzymes, fatty liver, hepatovirus infections, hyperinsulinemia and hyperuricemia.
